222 related articles for article (PubMed ID: 22937084)
21. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases.
Lee JH; Chiang SY; Nam D; Chung WS; Lee J; Na YS; Sethi G; Ahn KS
Cancer Lett; 2014 Apr; 345(1):140-8. PubMed ID: 24333736
[TBL] [Abstract][Full Text] [Related]
22. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
23. Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation.
Liu SH; Sheu WH; Lee MR; Lee WJ; Yi YC; Yang TJ; Jen JF; Pan HC; Shen CC; Chen WB; Tien HR; Sheu ML
J Pathol; 2013 Jun; 230(2):215-27. PubMed ID: 22553146
[TBL] [Abstract][Full Text] [Related]
24. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
25. A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Awazu Y; Nakamura K; Mizutani A; Kakoi Y; Iwata H; Yamasaki S; Miyamoto N; Imamura S; Miki H; Hori A
Mol Cancer Ther; 2013 Jun; 12(6):913-24. PubMed ID: 23548264
[TBL] [Abstract][Full Text] [Related]
26. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
27. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
Saraswati S; Alhaider A; Abdelgadir AM; Tanwer P; Korashy HM
Cell Commun Signal; 2019 Oct; 17(1):127. PubMed ID: 31619257
[TBL] [Abstract][Full Text] [Related]
28. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
29. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
30. Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.
Prasad S; Pandey MK; Yadav VR; Aggarwal BB
Cancer Prev Res (Phila); 2011 Jul; 4(7):1084-94. PubMed ID: 21490133
[TBL] [Abstract][Full Text] [Related]
31. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.
Ponnurangam S; Mammen JM; Ramalingam S; He Z; Zhang Y; Umar S; Subramaniam D; Anant S
Mol Cancer Ther; 2012 Apr; 11(4):963-72. PubMed ID: 22319203
[TBL] [Abstract][Full Text] [Related]
32. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
34. RING finger protein 38 induces gastric cancer cell growth by decreasing the stability of the protein tyrosine phosphatase SHP-1.
Zhang J; Wu H; Yi B; Zhou J; Wei L; Chen Y; Zhang L
FEBS Lett; 2018 Sep; 592(18):3092-3100. PubMed ID: 30112836
[TBL] [Abstract][Full Text] [Related]
35. β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase.
Kim C; Cho SK; Kapoor S; Kumar A; Vali S; Abbasi T; Kim SH; Sethi G; Ahn KS
Mol Carcinog; 2014 Oct; 53(10):793-806. PubMed ID: 23765383
[TBL] [Abstract][Full Text] [Related]
36. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.
Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML
Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429
[TBL] [Abstract][Full Text] [Related]
37. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
38. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
40. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1.
Gupta SC; Phromnoi K; Aggarwal BB
Biochem Pharmacol; 2013 Apr; 85(7):898-912. PubMed ID: 23279849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
